Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomas-Reference-Cited by-同舟云学术

Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomas

Published:2019-09-28 Issue:12 Volume:145 Page:3067-3073
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Kroschinsky Frank^ORCID,Röllig Denise,Riemer Barbara,Kramer Michael,Ordemann Rainer,Schetelig Johannes,Bornhäuser Martin,Ehninger Gerhard,Hänel Mathias

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-019-03027-6.pdf

Reference29 articles.

1. Abali H, Ürün Y, Öksüzoǧlu B et al (2008) Comparison of ICE (Ifosfamide–Carboplatin–Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma. Cancer Invest 26:401–406. https://doi.org/10.1080/07357900701788098

2. Albain KS, Swinnen LJ, Erickson LC et al (1990) Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model. Cancer Chemother Pharmacol 27:33–40. https://doi.org/10.1007/BF00689273

3. Bergerat J, Drewinko B, Corry P et al (1981) Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-β-d-arabinofuranosylcytosine. Cancer Res 41:25–30

4. Chida K, Morohashi G, Fuji H et al (2014) Implementation and evaluation of an efficient secure computation system using “R” for healthcare statistics. J Am Med Informatics Assoc 21:326–331. https://doi.org/10.1136/amiajnl-2014-002631

5. Coiffier B, Lepage E, Brière J et al (2002) CHOP chemotherapy plus Rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235–242

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Evidence of Relapsed/Refractory Mantle Cell Lymphoma Patients and Treatments: A Systematic Review;Journal of Blood Medicine;2024-05

2. Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure;Frontiers in Oncology;2021-06-18

3. Cisplatin/cytarabine/dexamethasone;Reactions Weekly;2019-12